COCP
Cocrystal Pharma Inc
NASDAQ: COCP · HEALTHCARE · BIOTECHNOLOGY
$1.39
+0.00% today
Updated 2026-04-29
Market cap
$19.71M
P/E ratio
—
P/S ratio
92.45x
EPS (TTM)
$-0.78
Dividend yield
—
52W range
$1 – $2
Volume
3.0M
Cocrystal Pharma Inc (COCP) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $12.61M | $17.19M | — | $9000.00 | $78000.00 | $0.00 | $0.00 | $0.00 | $6.56M | $2.01M | $5.43M | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | +36.4% | -100.0% | — | +766.7% | -100.0% | — | — | — | -69.3% | +169.5% | -100.0% | — | — | — |
| Cost of revenue | $1800.00 | $1800.00 | $4600.00 | $3800.00 | $8.64M | $9.97M | $3862.00 | $4071.00 | $192000.00 | $201000.00 | $101000.00 | $50000.00 | $4.00M | $6.03M | $8.79M | $12.39M | $15.17M | $12.54M | $376000.00 |
| Gross profit | $-1800.00 | $-1800.00 | $-4600.00 | $-3800.00 | $3.97M | $7.22M | $-3862.00 | $4929.00 | $-114000.00 | $-201000.00 | $-101000.00 | $-50000.00 | $2.56M | $-4.02M | $-8.79M | $-12.39M | $-15.17M | $-12.54M | $-376000.00 |
| Gross margin | — | — | — | — | 31.5% | 42.0% | — | 54.8% | -146.2% | — | — | — | 39.0% | -199.6% | -162.0% | — | — | — | — |
| R&D | — | — | — | — | $399624.00 | $743091.00 | $17499.00 | $4.07M | $47.26M | $101.68M | $5.82M | $58.57M | $4.00M | $6.03M | $8.79M | $12.39M | $15.17M | $12.54M | $5.05M |
| SG&A | $53833.00 | $55854.00 | $42848.00 | $49493.00 | $7.45M | $6.34M | $3.28M | $1.74M | $6.76M | $4.14M | $2.44M | $4.35M | $4.86M | $5.57M | $5.43M | $5.75M | $5.99M | $5.34M | $3.96M |
| Operating income | $-61524.00 | $-55854.00 | $-42848.00 | $-49493.00 | $-3.89M | $-2.64M | $-3.30M | $-5.80M | $-53.95M | $-105.82M | $-8.26M | $-62.92M | $-48.41M | $-9.59M | $-14.22M | $-38.83M | $-18.56M | $-17.88M | $-9.02M |
| Operating margin | — | — | — | — | -30.8% | -15.3% | — | -64433.3% | -69164.1% | — | — | — | -737.4% | -476.0% | -262.0% | — | — | — | — |
| EBITDA | $-61524.00 | $-53304.00 | $-42272.00 | $-49077.00 | $-3.68M | $-2.64M | $-3.85M | $-5.60M | $-53.76M | $-105.62M | $-7.39M | $-62.52M | $-2.21M | $-9.43M | $-14.03M | $-17.95M | $-20.97M | $-17.75M | $-8.64M |
| EBITDA margin | — | — | — | — | -29.2% | -15.3% | — | -62222.2% | -68917.9% | — | — | — | -33.6% | -468.2% | -258.5% | — | — | — | — |
| EBIT | $-59423.00 | $-53584.00 | $-42608.00 | $-49413.00 | $-4.21M | $-3.08M | $-3.98M | $-5.80M | $-53.95M | $-105.82M | $-7.49M | $-62.57M | $-2.30M | $-9.59M | $-14.22M | $-18.14M | $-21.16M | $-17.88M | $-9.02M |
| Interest expense | $0.00 | $0.00 | $0.00 | $439018.00 | $1.24M | $5.48M | $3.34M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $19000.00 | $8000.00 | $4000.00 | $2000.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-58723.00 | $-52917.00 | $-41370.00 | $-48478.00 | $-5.46M | $-7.96M | $-19.62M | $-99000.00 | $-50.12M | $-74.87M | $-613000.00 | $-49.05M | $-48.17M | $-9.65M | $-14.19M | $-38.84M | $-17.98M | $-17.50M | $-8.83M |
| Net income growth (YoY) | — | +9.9% | +21.8% | -17.2% | -11157.3% | -45.9% | -146.4% | +99.5% | -50528.3% | -49.4% | +99.2% | -7901.3% | +1.8% | +80.0% | -47.0% | -173.8% | +53.7% | +2.7% | +49.5% |
| Profit margin | — | — | — | — | -43.3% | -46.3% | — | -1100.0% | -64259.0% | — | — | — | -733.8% | -479.0% | -261.4% | — | — | — | — |